Extra-reference or partial replicate design [Software]

posted by d_labes  – Berlin, Germany, 2008-12-12 11:51 (5972 d 04:27 ago) – Posting: # 2912
Views: 31,678

Dear all,

FYI:
The 3-sequence-3-period replicate design with the sequences

TRR
RTR
RRT

mentioned in MGR's post above is handled in the framework of the so-called Method of moments in

[1] R.J. McNally
Tests for Individual and Population Bioequivalence Using 3-Period Crossover Designs

and the 2-sequence variant using only the two first sequences in

[2] S.-C. Chow, J. Shao and H. Wang
Individual bioequivalence testing under 2×3 designs
Statist. Med. 2002; 21:629–648

which can be found [1] here and [2] there.

These papers deal with individual BE but the parts relevant for average BE can easily extracted.

Interesting enough these papers state, that the intra-individual variance component for T(est) is not identifiable/estimable, due to the "partial" replicate nature of these designs (replicates only for R).
Thus one would expect some difficulties with the FDA SAS code, which has a covariance parameter for that in the model. But my little experimentation with it and some artificial data for an extra-reference design show that the code is able to deliver a value for that variance parameter sWT.
Black magic :confused: or some sort of perpetuum mobile of information?

Because the intra-individual variance for the Reference is identifiable (regardless which method, REML or method of moments) one could go with Reference scaled ABE as described in
Haidar et al.
Evaluation of a scaling approach for the bioequivalence of highly variable drugs
AAPS J. 2008 Sep;10(3):450-4. Epub 2008 Aug 26

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,699 registered users;
35 visitors (0 registered, 35 guests [including 8 identified bots]).
Forum time: 17:19 CEST (Europe/Vienna)

Do not put your faith in what statistics say until you have carefully
considered what they do not say.    William W. Watt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5